EMA Authorised: Galvus (vildagliptin) — Novartis Europharm Limited

View source ↗

Summary

The European Medicines Agency authorised the diabetes medicine Galvus (vildagliptin) for use in the EU, with Novartis Europharm Limited as the marketing authori…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Galvus (vildagliptin)

Snippet

Status: Authorised. Therapeutic area: Diabetes Mellitus, Type 2. MAH: Novartis Europharm Limited. Decision date: 28/01/2025